GSK - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

GSK reports positive data for Nucala in late-stage HES trial

GSK
GSK is developing mepolizumab to treat inflammatory diseases driven by eosinophils. Credit: GSK.